First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients

Summary

The primary objective of this trial is to assess the safety and tolerability of single and multiple ascending intravenously (IV) infused doses of CTX-187 when administered to healthy adult male and female participants and participants with a bacterial infection (bronchiectasis participants chronically infected with P. aeruginosa).

Timeline

Start

2026-06-16

Primary completion

2027-12-31

Completion

2027-12-31

Drugs

Indications